New joint initiative to explore clinical interpretation of molecular tests for cancer

Nikolaenko, E.M.; Proniaieva, Viktoriia Eduardivna

Please use this identifier to cite or link to this item: http://essuir.sumdu.edu.ua/handle/123456789/45978

Or use following links to share this resource in social networks: Recommend this item

Title	New joint initiative to explore clinical interpretation of molecular tests for cancer
Authors	Nikolaenko, E.M. Proniaieva, Viktoriia Eduardivna
ORCID
Keywords	cancer рак molecular tests молекулярні тести молекулярные тесты
Type	Conference Papers
Date of Issue	2016
URI	http://essuir.sumdu.edu.ua/handle/123456789/45978
Publisher	Sumy State University
License	Copyright not evaluated
Citation	Nikolaenko, E.M. New joint initiative to explore clinical interpretation of molecular tests for cancer [Текст] / E.M. Nikolaenko, V.E. Pronyaeva // With Foreign Languages to Mutual Understanding, Better Technologies and Ecologically Safer Environment : матеріали Х Всеукраїнської науково-практичної конференції студентів, аспірантів та викладачів лінгвістичного навчально-методичного центру кафедри іноземних мов, м. Суми, 24 березня 2016 р. / Відп. за вип. Г.І. Литвиненко. - Sumy : Sumy State University, 2016. - P. 62.
Abstract	New life requirements enforce doctors navigate one of the most important scientific questions faced by the cancer community could help improve survival rates for patients. A joint initiative of UNICANCER, ESMO and Cancer Research UK, the meeting on Molecular Analysis for Personalised therapy (MAP) will explore clinical interpretation of molecular tests for cancers that have spread.
Appears in Collections:	Наукові видання (ІФСК)